"19515-814-52" National Drug Code (NDC)

NDC Code	19515-814-52
Package Description	10 SYRINGE in 1 CARTON (19515-814-52) / .5 mL in 1 SYRINGE (19515-814-41)
Product NDC	19515-814
Product Type Name	VACCINE
Proprietary Name	Flulaval Quadrivalent
Proprietary Name Suffix	2023/2024
Non-Proprietary Name	Influenza Virus Vaccine
Dosage Form	SUSPENSION
Usage	INTRAMUSCULAR
Start Marketing Date	20230630
End Marketing Date	20240630
Marketing Category Name	BLA
Application Number	BLA125163
Manufacturer	ID Biomedical Corporation of Quebec
Substance Name	INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Strength	15; 15; 15; 15
Strength Unit	ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL